Document:

Exhibit 4.2

 

ASSIGNMENT OF WARRANT AGREEMENT, 

DATED AS OF MARCH 2012, 

BY AND AMONG ANDERSON STRUDWICK, INC.,

INVESTORS CAPITAL ALLIANCE, LLC 

AND 

SENSUS HEALTHCARE, LLC

 

ASSIGNMENT
OF

WARRANT AGREEMENT

 

THIS ASSIGNMENT OF
WARRANT AGREEMENT (“Assignment”) is made and entered into as of the 31 day of March, 2012, by and among Anderson
& Strudwick, Inc., a Virginia corporation (the “Assignor”), Investors Capital Alliance, LLC, a Delaware limited
liability company (“Assignee”) and Sensus Healthcare, LLC, a Delaware limited liability company (“Sensus”).

 

WHEREAS, Assignor acted
as placement agent to Sensus to arrange a private placement of its equity securities pursuant to certain engagement letter dated
March 15, 2010 between Assignor and Sensus (the “Agreement”).

 

WHEREAS, pursuant to
the Agreement, Assignor was to receive that certain warrant issued by Sensus to purchase equity in Sensus equal to six percent
(6%) of Sensus as of March 31, 2011, (the “Warrant”).

 

WHEREAS, Assignor has
requested that Sensus, rather than issuing the Warrant to Assignor, instead issue the warrant to Assignee.

 

NOW THEREFORE, in consideration
of the foregoing, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
the parties hereto agrees as follows:

 

1.          Representations
and Warranties of Assignor. Assignor hereby makes the following representations and warranties to Sensus.

 

(a)          Corporate
Status. Assignor is a corporation duly incorporated and validly existing under the laws of the State of Virginia.

 

(b)          Power
and Authority. Assignor has the power and authority to execute and deliver this Assignment, to perform its obligations hereunder
and to consummate the transactions contemplated hereby. Assignor has taken all action necessary to authorize the execution and
delivery of this Assignment, the performance of its obligations hereunder and the consummation of the transactions contemplated
hereby.

 

(c)          Enforceability.
This Assignment has been duly executed and delivered by Assignor and this Assignment constitutes the legal, valid and binding obligation
of Assignor, enforceable against it in accordance with its terms, except as the same may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium or similar laws affecting the enforcement of creditors’ rights generally and general equitable
principles regardless of whether such enforceability is considered in a proceeding at law or in equity.

 

     

     

    

 

(d)          No
Violation. The execution and delivery of this Assignment by Assignor, the performance by Assignor of its obligations hereunder
and the consummation by Assignor of the transactions contemplated hereby will not: (i) contravene any provision of its Articles
of Incorporation or Bylaws, (ii) violate or conflict with any law, statute, ordinance, rule, regulation, decree, writ, injunction,
judgment or order of any governmental or regulatory authority applicable to, binding upon or enforceable against Assignor, (iii)
result in or require the creation or imposition of any lien upon Assignor, or (iv) require the consent, approval, authorization
or permit of, or filing with or notification to, any governmental or regulatory authority, any court or tribunal or any other person
or entity.

 

(e)          Accuracy
of Information Furnished by Assignor. No statement or information made or furnished by Assignor herein contains or shall contain
any untrue statement of fact or omits or shall omit any fact necessary to make the information contained therein not misleading.

 

2.          Assignor’s
Assignment; Assignee’s Acceptance. Subject to the payment by Assignee to Sensus of $2,500 representing its legal costs
in connection with the review and preparation of this Assignment of Warrant Agreement, as provided by Section 6 hereof, Assignor
hereby transfers, grants, conveys and assigns to Assignee all of Assignor’s right, title and interest in the Warrant, and
Assignee does hereby accept such assignment from Assignor and assumes all obligations arising therefrom, from and after the date
hereof, relieving the Assignor from any liabilities associated therewith. The Warrant is attached hereto as Exhibit A.

 

3.          Indemnity
of Sensus.

 

(a)          Agreement
to Indemnify. The Assignor and Assignee, jointly and severally, agree to indemnify and hold Sensus and Sensus’ representatives,
affiliates, successors and assigns (each an “Indemnified Party”) harmless from and against any and all expenses, losses,
costs, deficiencies, liabilities and damages (including, without limitation, legal and court fees and expenses) incurred or suffered
by any Indemnified Party arising out of or resulting from (i) any breach of a representation or warranty made by Assignor in this
Assignment or in any other document or instrument delivered pursuant to this Assignment, (ii) any breach of the covenants or agreements
made by Assignor in this Assignment or in any other document or instrument delivered pursuant to this Assignment, and (iii) any
liability or obligation (whether absolute or contingent, liquidated or unliquidated, or due or to become due) arising from or related
to the transactions contemplated hereby (collectively, “Indemnifiable Damages”).

 

(b)          Survival
of Representations and Warranties. Each of the representations, warranties, covenants and agreements made by Assignor in this
Assignment shall survive the date hereof (along with the indemnification obligations contained in this Section 3).

 

(c)          Reliance
on Representations and Warranties. Notwithstanding any knowledge of facts determined or determinable by an Indemnified Party
by investigation, each Indemnified Party shall have the right to fully rely on the representations, warranties, covenants and agreements
of the Assignor contained in this Assignment or in any other documents or papers delivered in connection herewith. Each representation,
warranty, covenant and agreement contained in this Assignment is independent of each other representation, warranty, covenant and
agreement.

 

     

     

    

 

(d)          Third
Party Actions. Promptly after receipt by an Indemnified Party of notice of commencement of any action by a third party which
could give rise to Indemnifiable Damages, such Indemnified Party will notify the indemnifying party of the commencement thereof;
provided, however, that the failure to so notify the indemnifying party will not relieve the indemnifying party from any liability
or obligation hereunder unless the indemnifying party has been materially prejudiced thereby. The parties agree that with respect
to any third party action, any Indemnified Party may (i) assume the defense thereof with its own legal counsel, at the indemnifying
party’s sole cost and expense, (ii) provide the indemnifying party with all information that they reasonably request relating
to the handling of such claim, (iii) confer with the indemnifying party as to the most cost-effective manner in which to handle
such claim, and (iv) use its reasonable efforts to minimize the cost of handling such claim.

 

(e)          Cumulative
Remedies. The parties agree that, in connection with any breach or alleged breach by a party of the terms and provisions of
this Assignment, in addition to all other remedies available at law or hereunder, the injured party shall be entitled to equitable
relief, including injunctive relief and specific performance and all reasonable attorney’s fees and costs incurred in connection
therewith. All rights, powers and remedies afforded to a party under this Assignment, by law or otherwise, shall be cumulative
(and not alternative) and shall not preclude assertion or seeking by a party of any other rights or remedies.

 

4.          Counterparts.
This Assignment may be executed in one or more counterparts, each of which shall be deemed to be an original and all of which together
shall be deemed to be one and the same instrument.

 

5.          Entire
Assignment; No Third Party Beneficiaries. This Assignment (including the exhibits attached hereto) and other documents delivered
at the Closing, contains the entire understanding of the parties in respect of its subject matter and supersedes all prior agreements
and understandings (oral or written) between or among the parties with respect to such subject matter. This Assignment is not intended
to confer upon any Person, other than the parties hereto, any rights or remedies hereunder.

 

6.          Expenses.
Assignor shall pay the fees and expenses of Sensus, including its counsel fees, incurred in connection with this Assignment.

 

7.          Amendment;
Waiver. This Assignment may not be modified, amended, supplemented, canceled or discharged, except by written instrument executed
by all parties. No failure to exercise, and no delay in exercising, any right, power or privilege under this Assignment eement
shall operate as a waiver, nor shall any single or partial exercise of any right, power or privilege hereunder preclude the exercise
of any other right, power or privilege. No waiver of any breach of any provision shall be deemed to be a waiver of any preceding
or succeeding breach of the same or any other provision, nor shall any waiver be implied from any course of dealing between the
parties. No extension of time for performance of any obligations or other acts hereunder or under any other agreement shall be
deemed to be an extension of the time for performance of any other obligations or any other acts. The rights and remedies of the
parties under this Assignment are in addition to all other rights and remedies, at law or equity, that they may have against each
other.

 

     

     

    

 

8.          Binding
Effect; Assignment. The rights and obligations of this Assignment shall bind and inure to the benefit of the parties and their
respective successors and assigns. Nothing expressed or implied herein shall be construed to give any other person any legal or
equitable rights hereunder. The rights and obligations of this Assignment may not be assigned by the Assignor or Assignee without
the prior written consent of Sensus.

 

9.          Governing
Law; Severability. This Assignment shall be construed in accordance with and governed for all purposes by the laws of the State
of Florida applicable to contracts executed and to be wholly performed within such State. If any word, phrase, sentence, clause,
section, subsection or provision of this Assignment as applied to any party or to any circumstance is adjudged by a court to be
invalid or unenforceable, the same will in no way affect any other circumstance or the validity or enforceability of any other
word, phrase, sentence, clause, section, subsection or provision of this Assignment.

 

[Signature Page Follows]

 

     

     

    

 

IN WITNESS WHEREOF,
each of the parties has caused this Assignment of Warrant Agreement to be executed and delivered by its duly authorized officer
or agent as of the day and year first written above.

 

	 Witnesses:	 	ASSIGNOR:
	 	 	 
	/s/ Norma H. Sellors	 	ANDERSON & STRUDWICK, INC.
	Print Name:     Norma H. Sellors	 	 
	 	 	By:	/s/ Donald H. Newlin
	/s/ Debra B. Leimer	 	Name:	Donald H. Newlin
	Print Name:     Debra B. Leimer	 	Title:	Chairman

 

	Witnesses:	 	ASSIGNEE
	 	 	 
	/s/ Kelley B. Simpson	 	INVESTORS CAPITAL ALLIANCE, LLC
	Print Name:     Kelley B. Simpson	 	 
	 	 	By:	/s/ Milton A. Turner
	/s/ Lorraine Rajkowski	 	Name:	Milton A. Turner
	Print Name:     Lorraine Rajkowski	 	Title:	Chief Manager

 

	 	 	SENSUS HEALTHCARE, INC.
	 	 	 	 
	Print Name:	 	 	 
	 	 	By:	 
	 	 	Name:	 
	Print Name:	 	Title:Exhibit 4.4

 

FORM OF WARRANT AGREEMENT OF 

SENSUS HEALTHCARE, LLC, 

DATED AS OF FEBRUARY 1, 2013, 

BY AND BETWEEN SENSUS HEALTHCARE, LLC

AND CERTAIN INVESTORS

 

THE SECURITIES REPRESENTED BY THIS WARRANT,
INCLUDING THE LIMITED LIABILITY COMPANY MEMBERSHIP INTERESTS ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS AND NEITHER SUCH SECURITIES NOR ANY INTEREST
THEREIN MAY BE OFFERED, SOLD, PLEDGED, ASSIGNED OR OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THERETO
IS EFFECTIVE UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS, OR (2) THE COMPANY RECEIVES AN OPINION OF COUNSEL
REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH SECURITIES MAY BE OFFERED, SOLD, PLEDGED,ASSIGNED OR TRANSFERRED IN THE MANNER
CONTEMPLATED PURSUANT TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS UNDER THE SECURITIES ACT OR APPLICABLE STATE SECURITIES
LAWS. THE TRANSFERABILITY OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE IS ALSO LIMITED IN ACCORDANCE WITH THE TERMS OF THE
COMPANY’S OPERATING AGREEMENT.

 

WARRANT AGREEMENT

 

of

 

SENSUS HEALTHCARE, LLC

 

	Dated as of:	 	February 1, 2013 (the “Effective Date”) 
	Expiration Date:	 	February 1, 2018

 

WHEREAS, Sensus
Healthcare, LLC, a Delaware limited liability company (the “Company”), has entered into an Engagement Letter dated
November 8, 2012, and a Placement Agent Agreement, undated, with Neidiger, Tucker, Bruner, Inc., a COLORADO corporation
(“NTB”);

 

WHEREAS, the
Company desires to grant NTB or its designees (the “Holder”), the right to purchase Units (as hereinafter defined)
in the Company in accordance with the terms and conditions of this Warrant Agreement (the “Agreement or the “Warrant”).

 

WHEREAS, NTB
has named ________________ as one of its designees.

 

NOW, THEREFORE,
in consideration of the mutual covenants and agreements contained herein, and other good and valuable consideration the receipt
and sufficiency of which is hereby acknowledged, the Company and Holder hereby agree as follows:

 

     

     

    

 

FOR VALUE RECEIVED,
the Company hereby grants to Holder or its permitted assigns, and the Holder is entitled, upon the terms and subject to the conditions
hereinafter set forth, to subscribe for and purchase from the Company, units representing limited liability company membership
interests in the Company (the “Units”). The number of Units (the “Amount”), that the Holder may purchase
from the Company shall be ___ as of the Effective Date, as more fully described herein. The Units do not provide for any
distribution preferences or preferred return. The exercise price of the Units shall be $_____________ (the “Exercise
Price”), and is payable in cash. The Exercise Price may be adjusted from time to time in accordance with Section 3 hereof,
according to the terms, conditions and procedures set forth herein. This Warrant (the “Warrant”) will expire at 5:00
p.m. (Eastern Time), on February _l_, 2018 (the “Expiration Date”), five years after the Effective Date. The Units
issued upon exercise of this Warrant, shall sometimes be referred to herein as “Warrant Units”. The Company may at
some time reorganize as a C corporation and any references to “Warrant Units” shall refer to shares of the Company’s
common stock (“Common Stock”) which are issued in exchange for the Warrant Units. This Warrant is subject to the following
terms and conditions:

 

1.             EXERCISE;
PAYMENT; ISSUANCE OF CERTIFICATES

 

Any purchase of Units
by Holder hereunder shall be made pursuant to the following terms and procedures:

 

1.1           Holder
electing to purchase Units must surrender this Warrant and deliver the exercise form attached hereto as Exhibit A (the “Exercise
Form”), together with the investment representation letter attached hereto as Exhibit B, each duly completed and executed,
to the Company at its principal office (or at such other location as the Company may advise the Holder in writing), along with
payment in full of the aggregate Exercise Price (“Purchase Price”) for the full Amount, no later than the Expiration
Date hereof. The Holder must also, as a condition to the purchase, execute the Operating Agreement of the Company. The Holder may
exercise this Warrant in full or in part at any time prior to the Expiration Date.

 

1.2           Payment
of the Purchase Price may be made, at the discretion of the Holder by (i)(i) cash, (ii) certified check, (iii) wire transfer of
funds to the Company, (iv) any combination of the foregoing or (iv) a cashless exercise on or after May _1_, 2013 as follows: the
Holder shall be entitled to receive a certificate for the number of Warrant Units equal to the quotient obtained by dividing [(A-B)
(X)] by (A),where:

 

(A) = the ten.
(10) day average trading price the Company’s Common Stock on the exchange, inter-dealer communication system or national
quotation bureau where the Company’s Common Stock is listed immediately preceding the exercise date of the Warrant. In the
event, the Company’s Common Stock is not publicly traded, the cashless exercise will be permissible based on an assumed price
equivalent to ____ per Unit.

 

(B) = the Exercise
Price of this Warrant, as adjusted hereunder; and

 

(X) = the number
of Warrant Units that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise
were by means of a cash exercise rather than a cashless exercise.

 

     

     

    

 

1.3           If
Holder fails to deliver the Exercise Form and the investment representation letter to the Company by the Expiration Date, properly
completed and executed, along with payment in full of the Purchase Price for the Units to be purchased thereunder and the executed
Operating Agreement, this Warrant shall expire and all rights granted pursuant to this Warrant shall automatically terminate and
Holder shall waive its right to purchase any Units hereunder.

 

1.4           The
Company agrees that the Units to be purchased hereunder upon exercise of this Warrant shall be and are deemed to be issued to the
Holder hereof as the record owner of such Units as of the close of business on the date on which Holder has delivered to the Company
the Exercise Form and the investment representation letter hereunder, properly completed and executed, along with payment in full
for the Units purchased thereunder and the executed Operating Agreement of the Company. If this Warrant should be exercised in
part only, the Company shall, upon surrender of this Warrant for cancellation, execute and deliver a new Warrant evidencing the
rights of the Holder hereto to the purchase the balance of the Warrant Units purchase hereunder.

 

1.5           The
Company may, at its option and sole discretion issue a certificate for the Units purchased hereunder, and deliver such certificate
to the Holder hereof.

 

2.             EXERCISE
PRICE; UNITS TO BE FULLY PAID; ISSUANCE OF ADDITIONAL PERCENTAGE INTERESTS

 

2.1           The
Exercise Price for the Units is $___________, subject to adjustment as set forth hereinafter. The Units to be issued by
the Company upon exercise hereof shall be ___.

 

2.2           The
Company covenants and agrees that all Units which may be issued upon the exercise of the rights represented by this Warrant will,
upon issuance, be duly authorized, validly issued, fully paid and nonassessable and free from all preemptive rights of any person
and free of all taxes, liens and charges with respect to the issue thereof.

 

2.3           The
Warrant provides for the purchase of ____ Units of the Company, as of the Effective Date. The Holder acknowledges and agrees
that the issuance by the Company of additional Units or any other types or forms of membership interests in the Company, including
the existing preferred membership interest of the Company, after the Effective Date, will reduce the Holder’s proportionate
membership interests with respect to the Company.

 

3.             ADJUSTMENT
OF EXERCISE PRICE

 

3.1           The
Exercise Price is subject to adjustment in accordance with this Section 3 and from time to time upon the occurrence of certain
events described in this Section 3.

 

3.2           In
the event the Company shall, at any time or from time to time after the Effective Date, issue Units as a dividend to the beneficial
holders of Units, or subdivide or combine the outstanding Units into a greater or lesser number (any such issuance, subdivision
or combination being herein called a “Capital Change”), then, and thereafter upon each such Capital Change, the Exercise
Price in effect immediately prior to such Capital Change shall be changed to a price (including any applicable fraction of a cent)
determined by dividing (a) the total number of Units outstanding, on a fully diluted basis, immediately prior to such Capital Change,
multiplied by the Exercise Price in effect immediately prior to such Capital Change, by (b) the total number of Units outstanding,
on a fully diluted basis, immediately after such Capital Change.

 

     

     

    

 

3.3           In
the case of any reclassification, capital reorganization or other equivalent change of outstanding Units, the Company shall cause
effective provision to be made so that the Holder shall have the right thereafter, by exercising this Warrant, to purchase the
kind and number of Units or other securities or property (including cash) received upon such reclassification, capital reorganization
or other change, that might have been acquired upon exercise of this Warrant immediately prior to such reclassification , capital,
reorganization or other change. Any such provision shall include provision for adjustments that shall be as nearly equivalent as
may be practicable to the adjustments provided for in this Section 3. The foregoing provisions shall similarly apply to successive
reclassifications, capital reorganizations and other equivalent changes of outstanding Units.

 

4.             ISSUE
TAX

 

In the event the Company
elects to issue a certificate or certificates for the Units purchased hereunder, such issuance of certificates shall be made without
charge to the Holder of the Warrant for any issue tax (other than any applicable income taxes) in respect thereof; provided, however,
that the Company shall not be required to pay any tax which may be payable in respect of any transfer involved in the issuance
and delivery of any certificate in a name other than that of the then Holder of the Warrant being exercised.

 

5.             CLOSING
OF BOOKS

 

The Company will at
no time close its transfer books against the transfer of any Warrant or of any Units, or take any action in any manner which interferes
with the timely exercise of this Warrant.

 

6.             NO
VOTING OR DIVIDEND RIGHTS; LIMITATION OF LIABILITY

 

Except as otherwise
provided hereunder, until such time as the Holder exercises its right to purchase the Units and complete the purchase of the Units
contemplated hereby, nothing contained in this Warrant shall be construed as conferring upon the Holder hereof any rights as a
member of the Company including, but not limited to, the right to vote, or to consent, or to receive notice as a member of the
Company, or any rights to a dividend or distribution. No provisions hereof, in the absence of affirmative action by the Holder
to purchase Units, and no mere enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
such Holder for the Exercise Price or as a member of the Company, whether such liability is asserted by the Company or by its creditors.

 

7.             REGISTRATION
RIGHTS.

 

Pursuant to a Registration
Rights Agreement dated as of even date herewith between the Company and the Holder, certain registration rights apply to the Warrant
Units issuable upon exercise of this Warrant. See the Registration Rights Agreement for a full description of the registration
rights applicable to such shares of Common Stock and the limitations on such rights.

 

     

     

    

 

8.             MODIFICATION
AND WAIVER; NOTICES

 

This Warrant and any
provision hereof may be changed, waived, discharged or terminated only by an instrument in writing signed by the Company and the
Holder. All notices required or permitted hereunder shall be in writing and shall be deemed effectively given: (a) upon personal
delivery to the party to be notified, (b) when sent by confirmed facsimile if sent during normal business hours of the recipient,
if not, then on the next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt
requested, postage prepaid, or (d) one (1) day after deposit with a nationally recognized overnight courier, specifying next day
delivery, with written verification of receipt. All communications shall be sent to the Holder at the Holder’s address as
shown on the books of the Company or to the Company at the address indicated therefor in the first paragraph of this Warrant or
such other address as either may from time to time provide to the other.

 

9.             BINDING
EFFECT ON SUCCESSORS

 

This Warrant shall
be binding upon any business entity succeeding the Company by merger, consolidation or acquisition of all or substantially all
of the Company’s assets. All of the covenants and agreements of the Company shall inure to the benefit of the successors
and assigns of the Holder hereof. This Warrant may not be assigned by Holder without the prior written consent of the Company.
If this Warrant is assigned pursuant to the terms hereof, the term “Holder” shall be deemed to refer to the permitted
assignee(s).

 

10.            DESCRIPTIVE
HEADINGS AND GOVERNING LAW

 

The description headings
of the several sections and paragraphs of this Warrant are inserted for convenience only and do not constitute a part of this Warrant.
This Warrant shall be construed and enforced in accordance with, and the rights of the parties shall be governed by, the laws of
the State of Florida, without giving effect to the conflict of laws principles thereof.

 

11.            LOST
WARRANT

 

The Company represents
and warrants to the Holder hereof that upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction,
or mutilation of this Warrant and, in the case of any such loss, theft or destruction, upon receipt of an indemnity reasonably
satisfactory to the Company, or in the case of any such mutilation upon surrender and cancellation of such Warrant, the Company,
at its expense, will make and deliver a new warrant, of like tenor, in lieu of the lost, stolen, destroyed or mutilated Warrant.

 

[REMAINDER OF PAGE LEFT INTENTIONALLY BLANK;

SIGNATURE PAGE FOLLOWS]

 

     

     

    

 

IN WITNESS WHEREOF,
the Company has caused this Warrant to be duly executed by its officer thereunto duly authorized as of this 1st day of February
2013.

 

	 	THE COMPANY:
	 	 
	 	SENSUS HEALTHCARE, LLC
	 	 	 
	 	By:  	 

 

     

     

    

 

EXHIBIT A

 

EXERCISE FORM

 

____________________, 201___

 

Sensus Healthcare, LLC 

 

Ladies and Gentlemen:

 

The undersigned holder (“Holder”)
of that certain Warrant (the “Warrant”), issued by Sensus Healthcare, LLC (the “Company”)
and dated February 2013, hereby exercises its right to purchase pursuant thereto the number of Units of the Company (“Warrant
Interests”) at an exercise price (“Exercise Price”) and aggregate purchase price (the “Purchase
Price”) listed immediately below:

 

	Number of Warrant Interests	 	 	Exercise Price	 	 	 	Aggregate Purchase Price	 
	 	 	 	 	 	 	 	 	 
	______ of Units	 	$	                 	 	 	$	                 	 

 

If Cash Exercise

 

The Holder delivers the Purchase Price
herewith in cash, by certified check, or by wire transfer pursuant to Section 1.2(i), (ii), (iii) or (iv) of the Warrant according
to the following instructions:

 

	 	______________________
	 	______________________
	 	______________________
	 	Account No.:
	 	Routing Number:

 

If Cashless Exercise

 

The Holder elects to convert the Warrant
into ____ Warrant Units pursuant to the cashless exercise provision contained in Section 1.2(iv) of the Warrant. This conversion
is exercised with respect to ____ Warrant Units covered by the Warrant.

 

The Holder also makes the representations
set forth on the attached Exhibit B to the Warrant.

 

Very truly yours,

 

HOLDER:

 

	NAME: 	 	 
	 	print name of individual or entity	 

 

     

     

    

 

	IF HOLDER IS AN INDIVIDUAL:	 
	 	 
	By:	 	 
	 	 	 
	 	signature	 

 

	IF HOLDER IS AN ENTITY:	 
	 	 
	Name: 	 	 
	 	print name of person signing for entity	 
	 	 	 
	Title: 	 	 
	 	print title of person signing/or entity	 

 

	ADDRESS:	 
	 	 
	STREET: ___________________________	 
	CITY: ___________________________	 
	STATE AND ZIP: ___________________________	 
	FACSIMILE: ___________________________	 

 

     

     

    

 

EXHIBIT B

 

INVESTMENT REPRESENTATION LETTER

 

THIS INVESTMENT REPRESENTATION LETTER MUST
BE COMPLETED, SIGNED AND RETIJRNED TO SENSUS HEALTHCARE, LLC, ALONG WITH THE ASSOCIATED EXERCISE FORM(S) BEFORE THE MEMBERSHIP
INTERESTS ISSUABLE UPON EXERCISE OF THE WARRANT WITH AN EFFECTIVE DATE OF FEBRUARY __, 2013 WILL BE ISSUED.

 

________________, 201__

 

SENSUS HEALTHCARE, LLC

 

Ladies and Gentlemen:

 

Pursuant to the exercise that certain Warrant,
with an Effective Date of February 2013 (the “Warrant”), issued by SENSUS HEALTHCARE, LLC (the “Company”),
the undersigned holder of the Warrant (“Purchaser”) intends to purchase Units representing limited liability
company membership interests in the Company. The Units will be issued to Purchaser in a transaction not involving a public offering
and pursuant to an exemption from registration under the United States Securities Act of 1933, as amended (the “33 Act”),
and applicable state securities laws. In connection with such purchase and in order to comply with the exemptions from registration
relied upon by the Company, Purchaser represents, warrants and agrees as follows:

 

1.          Purchaser
is acquiring the Units for its own account, for investment purposes only, without the intent toward the further sale or distribution
thereof, and Purchaser shall not make any sale, transfer or other disposition of the Units in violation of the 33 Act or the General
Rules and Regulations promulgated thereunder by the Securities and Exchange Commission or in violation of any other applicable
securities law.

 

2.          Purchaser
has been advised that the Units have not been registered under the 33 Act or any state securities laws on the ground that this
transaction is exempt from registration, and that reliance by the Company on such exemptions is predicated in part on Purchaser’s
representations set forth in this letter.

 

3.          Purchaser
has been informed that under the 33 Act, the Units must be held indefinitely unless subsequently registered under the 33 Act or
unless an exemption from such registration (such as Rule 144) is available with respect to any proposed transfer or disposition
by Purchaser of the Units.

 

Very truly yours,

 

PURCHASER:

 

	NAME: 	 	 
	 	print name of individual or entity	 

 

     

     

    

 

	IF PURCHASER IS AN INDIVIDUAL:	 
	 	 	 
	By:	 	 
	 	signature	 

 

	IF PURCHASER IS AN ENTITY:	 
	 	 	 
	Name:	 	 
	 	print name of person signing for entity	 
	 	 	 
	Title: 	 	 
	 	print title of person signing/or entity

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}]]